SPOTLIGHT: Eclipsys reports Q3 numbers, draws attention

Expect Wall Street to pay close attention to how healthcare information system company Eclipsys performs over the quarter to come. Yesterday, the company announced its third-quarter revenue was $97.9 million, an increase of 23 percent over last year. This week Eclipsys named Andrew Eckert CEO, solidifying its management team. With shares priced at around $16, the company is seen as a bargain by some analysts, who feel the company is poised to overcome some problems with a technology transition and compete with the bigger names in the sector. Release